US 11234971
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted A61KA61K31/337A61K31/444
Quick answer
US patent 11234971 (Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent) held by Corcept Therapeutics Incorporated expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/337, A61K31/444, A61K31/4545, A61K45/06